{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:08:39Z","timestamp":1761556119425,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.sapharm.2007.07.001","type":"journal-article","created":{"date-parts":[[2008,8,13]],"date-time":"2008-08-13T17:42:15Z","timestamp":1218649335000},"page":"284-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hypertension management in outpatient visits by diabetic patients"],"prefix":"10.1016","volume":"4","author":[{"given":"Rajender R.","family":"Aparasu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Aparasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2007.07.001_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/ajkd.2000.16225","article-title":"Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group","volume":"36","author":"Bakris","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.sapharm.2007.07.001_bib2","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/00004872-199715022-00004","article-title":"Diabetes and hypertension: the bad companions","volume":"15","author":"Epstein","year":"1997","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.sapharm.2007.07.001_bib3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/bmj.313.7060.779","article-title":"Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study","volume":"313","author":"Rossing","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.sapharm.2007.07.001_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0021-9150(99)00217-8","article-title":"Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study","volume":"148","author":"Forrest","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.sapharm.2007.07.001_bib5","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2337\/diab.43.4.572","article-title":"Incidence of renal failure in NIDDM. The Oklahoma Indian Diabetes Study","volume":"43","author":"Lee","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.sapharm.2007.07.001_bib6","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.2337\/diacare.26.8.2353","article-title":"Low incidence of end-stage renal disease and chronic renal failure in type 2 diabetes: a 10-year prospective study","volume":"26","author":"Bruno","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.sapharm.2007.07.001_bib7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bmj.321.7258.412","article-title":"Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study","volume":"321","author":"Adler","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.sapharm.2007.07.001_bib8","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2337\/diacare.24.6.1053","article-title":"Pittsburgh Epidemiology of Diabetes Complications Study. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study","volume":"24","author":"Orchard","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.sapharm.2007.07.001_bib9","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.2337\/diacare.26.2007.S80","article-title":"Treatment of hypertension in adults with diabetes","volume":"26","author":"Arauz-Pacheco","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.sapharm.2007.07.001_bib10","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.sapharm.2007.07.001_bib11","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.2337\/diacare.27.2007.S65","article-title":"Hypertension management in adults with diabetes","volume":"27","author":"Arauz-Pacheco","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.sapharm.2007.07.001_bib12","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease","volume":"43","author":"Kidney Disease Outcomes Quality Initiative (K\/DOQI)","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.sapharm.2007.07.001_bib13","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/ndt\/10.11.1963","article-title":"Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials","volume":"10","author":"Gansevoort","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.sapharm.2007.07.001_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy","volume":"355","author":"Heart Outcomes Prevention Evaluation Study Investigators","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.sapharm.2007.07.001_bib15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sapharm.2007.07.001_bib16","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jacc.2005.05.051","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials","volume":"46","author":"Abuissa","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.sapharm.2007.07.001_bib17","first-page":"124","article-title":"Evaluation of angiotensin-converting enzyme inhibitor use in patients with type 2 diabetes in a state managed care plan","volume":"10","author":"Timpe","year":"2004","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.sapharm.2007.07.001_bib18","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1525-1497.2004.30264.x","article-title":"Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes","volume":"19","author":"Rosen","year":"2004","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.sapharm.2007.07.001_bib19","first-page":"303","article-title":"Blood pressure goal attainment according to JNC 7 guidelines and utilization of antihypertensive drug therapy in MCO patients with type 1 or type 2 diabetes","volume":"12","author":"Andros","year":"2006","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.sapharm.2007.07.001_bib20","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1053\/j.ajkd.2005.08.018","article-title":"Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes","volume":"46","author":"Winkelmayer","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.sapharm.2007.07.001_bib21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1525-1497.2006.00351.x","article-title":"Indications for and utilization of ACE inhibitors in older individuals with diabetes. Findings from the National Health and Nutrition Examination Survey 1999 to 2002","volume":"21","author":"Rosen","year":"2006","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.sapharm.2007.07.001_bib22","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/archinte.164.10.1134","article-title":"Trends in complexity of diabetes care in the United States from 1991 to 2000","volume":"164","author":"Grant","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sapharm.2007.07.001_bib23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2337\/diacare.29.03.06.dc05-1254","article-title":"Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey","volume":"29","author":"Resnick","year":"2006","journal-title":"Diabetes Care"},{"author":"National Center for Health Statistics","key":"10.1016\/j.sapharm.2007.07.001_bib24"},{"author":"National Center for Health Statistics","key":"10.1016\/j.sapharm.2007.07.001_bib25"},{"author":"National Center for Health Statistics","key":"10.1016\/j.sapharm.2007.07.001_bib26"},{"author":"National Center for Health Statistics","key":"10.1016\/j.sapharm.2007.07.001_bib27"},{"unstructured":"US Department of Health and Human Services. Centers for Disease Control and Prevention. Health Care Financing Administration. International Classification of Diseases, 9th Revision, Clinical Modification. 6th edition. 2004.","key":"10.1016\/j.sapharm.2007.07.001_bib28"},{"key":"10.1016\/j.sapharm.2007.07.001_bib29","first-page":"1","article-title":"The collection and processing of drug information. National Center for Health Statistics","volume":"2","author":"Koch","year":"1982","journal-title":"Vital Health Stat"},{"year":"2006","series-title":"AHFS Drug Information 2006","key":"10.1016\/j.sapharm.2007.07.001_bib30"},{"unstructured":"Shah BV, Barnwell BG, Bieler GS. SUDAAN User's Manual: Research Triangle Park, NC: Research Triangle Institute. Software for Analysis of Correlated Data, Release 8.0; 2002.","key":"10.1016\/j.sapharm.2007.07.001_bib31"},{"key":"10.1016\/j.sapharm.2007.07.001_bib32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/archinte.163.5.525","article-title":"Management of high blood pressure in African Americans. Consensus statement of the hypertension in African Americans Working Group of the International Society on Hypertension in Blacks","volume":"163","author":"Douglas","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sapharm.2007.07.001_bib33","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1161\/01.CIR.99.18.2389","article-title":"Rising tide of cardiovascular disease in American Indians. The Strong Heart Study","volume":"99","author":"Howard","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.sapharm.2007.07.001_bib34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1524-6175.2006.05112.x","article-title":"Hypertension in minority populations","volume":"8","author":"Ferdinand","year":"2006","journal-title":"J Clin Hypertens"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741107000733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741107000733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:05:26Z","timestamp":1761555926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741107000733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1551741107000733"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2007.07.001","relation":{},"ISSN":["1551-7411"],"issn-type":[{"type":"print","value":"1551-7411"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertension management in outpatient visits by diabetic patients","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2007.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}